Anastrozole
Therapeutic Indications
Anastrozole is indicated for:
Hormone receptor-positive breast cancer in postmenopausal women
Women only, only Adults (18 years old or older)
Anastrozole is indicated for the:
- Treatment of hormone receptor-positive advanced breast cancer in postmenopausal women.
- Adjuvant treatment of hormone receptor-positive early invasive breast cancer in postmenopausal women.
- Adjuvant treatment of hormone receptor-positive early invasive breast cancer in postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Oral - 1 mg once a day
Contraindications
Active ingredient Anastrozole is contraindicated in the following cases:
Lactation
No gender/age discrimination
There are no data on the use of anastrozole during lactation. Anastrozole is contraindicated during breastfeeding.
Pregnancy
No gender/age discrimination
There are no data from the use of anastrozole in pregnant women. Studies in animals have shown reproductive toxicity. Anastrozole is contraindicated during pregnancy.